Latest News and Press Releases

Delhi, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Global Gamma Delta T Cell Cancer Therapy Market Opportunity and Clinical Trials Insight 2030 Report Conclusions: Number Of Gamma Delta T Cell Therapies In...

Delhi, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies and Clinical Trials Insight 2028 Report Highlights: Global Targeted...

Delhi, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Global DLL3 Targeted Therapies Market, Approved Drugs Dosage, Pricing & Clinical Trials Insight 2025 Report Finding and Highlights: Global &...

Delhi, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The cancer peptide drugs market has experienced significant growth in recent years, with over 30 peptide-based therapies currently approved for clinical use...

Delhi, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Global mRNA Cancer Vaccines Clinical Trials and Market Future Outlook 2024 Report Highlights: mRNA Cancer Vaccines In Clinical Trials: > 60...

Delhi, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Molecular Switches As Therapeutic Targets, Drug Development, Drug Delivery Mechanism & Application By Indications Insight 2025 Research Insights: Top 20...

Delhi, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: Bispecific Antibodies Development...

Delhi, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The recent approval of sacituzumab tirumotecan in China represents a significant advancement in oncology, particularly in the realm of targeted therapies....

Delhi, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights: Global Targeted...

Delhi, Dec. 05, 2024 (GLOBE NEWSWIRE) -- GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030 Report Highlights: GCC Pharmaceutical Market Opportunity: > US$ 12 Billion By ...